Impact of type 2 diabetes on adenoma detection in screening colonoscopies performed in disparate populations

Table 9 Estimated odds ratios and 95% confidence intervals of the risk factors for adenoma detection rate based on a multivariable generalized linear mixed model

Factors	Levels	OR with 95%CI	P value
T2DM	T2DM vs NoDM	1.29 (1.08-1.55)	0.0049
Age (yr)	Every 1 year increase in age	1.05 (1.04-1.06)	< 0.0001
BMI kg/m²	Every 1 unit increase in BMI	1.02 (1.01-1.03)	0.0003
Sex	Male vs Female	1.87 (1.62-2.15)	< 0.0001
Race	Black vs White	0.93 (0.69-1.24)	0.8020
	Asian vs White	1.19 (0.74-1.91)
	Other vs White	1.02 (0.72-1.44)
Insurance	Medicare vs Commercial	0.9 (0.68 -1.18)	0.0582
	Medicaid vs Commercial	1.25 (1.04-1.5)
	Self-pay vs Commercial	1.1 (0.83-1.45)
Aspirin use	Yes vs No	0.97 (0.80-1.18)	0.7966
Smoking	Current vs Past	1.32 (1.02-1.70)	0.0026
	Current vs Never	1.47 (1.18-1.82)

CI: Confidence intervals; BMI: Body mass index; T2DM: Type 2 diabetes mellitus; NoDM: Nondiabetics; OR: Odds ratio.